David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALEX
1751
DELISTED
Alexander & Baldwin
ALEX
| $4.62M | 0.01% |
+220,412
| New | +$4.99M |
|
1752
iShares Biotechnology ETF
IBB
$10.8B
| $4.61M | 0.01% |
+38,250
| New | +$4.27M |
|
1753
Ventas
VTR
$48B
| $4.61M | 0.01% |
79,841
+61,617
| +338% | +$3.87M |
|
|
TBRG
1754
DELISTED
TruBridge
TBRG
| $4.61M | 0.01% |
174,497
+24,859
| +17% | +$620K |
|
1755
PUT
The Greenbrier Companies
GBX
$1.43B
| $4.6M | 0.01% |
141,800
-39,200
| -22% | -$1.17M |
|
1756
Allegiant Air
ALGT
$2.26B
| $4.6M | 0.01% |
26,414
+13,399
| +103% | +$2.22M |
|
1757
CALL
WEC Energy
WEC
$35B
| $4.58M | 0.01% |
49,700
+23,500
| +90% | +$2.14M |
|
1758
PUT
Phillips 66
PSX
$96.7B
| $4.56M | 0.01% |
40,900
-57,400
| -58% | -$6.45M |
|
|
APLS
1759
DELISTED
Apellis Pharmaceuticals
APLS
| $4.54M | 0.01% |
148,407
+137,342
| +1,241% | +$3.8M |
|
1760
CALL
Huntington Ingalls Industries
HII
$11.7B
| $4.54M | 0.01% |
+18,100
| New | +$4.29M |
|
|
DPLO
1761
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $4.54M | 0.01% |
1,134,345
-29,662
| -3% | -$139K |
|
1762
AZZ Inc
AZZ
$4.23B
| $4.53M | 0.01% |
98,674
+24,941
| +34% | +$1.02M |
|
1763
Arvinas
ARVN
$609M
| $4.52M | 0.01% |
+109,937
| New | +$3.22M |
|
1764
Banner Corp
BANR
$2.39B
| $4.52M | 0.01% |
79,812
+5,020
| +7% | +$278K |
|
|
GWB
1765
DELISTED
Great Western Bancorp, Inc.
GWB
| $4.51M | 0.01% |
129,935
+24,564
| +23% | +$849K |
|
1766
PTC
PTC
$16.5B
| $4.51M | 0.01% |
60,228
+55,022
| +1,057% | +$3.91M |
|
1767
CALL
PVH
PVH
$3.62B
| $4.49M | 0.01% |
42,700
-3,400
| -7% | -$324K |
|
1768
Regal Rexnord
RRX
$11B
| $4.48M | 0.01% |
52,336
+25,872
| +98% | +$2.05M |
|
|
ZUO
1769
DELISTED
Zuora, Inc.
ZUO
| $4.48M | 0.01% |
312,627
+102,209
| +49% | +$1.5M |
|
1770
CALL
Raymond James Financial
RJF
$34B
| $4.47M | 0.01% |
75,000
| – | – |
|
1771
Pebblebrook Hotel Trust
PEB
$2.07B
| $4.46M | 0.01% |
166,276
+91,837
| +123% | +$2.42M |
|
|
MIC
1772
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $4.46M | 0.01% |
104,036
-61,147
| -37% | -$2.52M |
|
|
WBK
1773
DELISTED
Westpac Banking Corporation
WBK
| $4.45M | 0.01% |
262,007
+241,713
| +1,191% | +$4.37M |
|
1774
CALL
Sysco
SYY
$39.9B
| $4.45M | 0.01% |
+52,000
| New | +$4.21M |
|
|
CLVS
1775
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.45M | 0.01% |
426,531
-1,335,983
| -76% | -$9.71M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.